Literature DB >> 22334683

Regulation of the human plasminogen activator inhibitor type 2 gene: cooperation of an upstream silencer and transactivator.

Brett Stringer1, Ekemini A Udofa, Toni M Antalis.   

Abstract

Transcriptional up-regulation of the plasminogen activator inhibitor type-2 (PAI-2) gene is a major response to cellular stress. The expression of PAI-2 is induced by a variety of cytokines and growth factors that act in a cell type- and differentiation stage-dependent manner. We previously reported that the human SERPINB2 gene promoter is controlled by three major transcription regulatory domains: an inducible proximal promoter, an upstream silencer (PAUSE-1), and a distal transactivator region between -5100 and -3300, which appears to overcome inhibition mediated by the silencer. The distal transactivator region is inducible by the phorbol ester PMA, a potent activator of the protein kinase C (PKC) pathway that is a powerful inducer of PAI-2 gene expression in monocytes, macrophages, and myelomonocytic cells as well as in epidermal keratinocytes. Here we show that a 21-bp region (-4952/-4932), containing an AP-1 element, is both necessary and sufficient for PMA-induced transactivator activity in PAI-2-expressing U937 cells. This site specifically binds FosB in PAI-2-expressing U937 cells but not in HeLa cells that do not express PAI-2, and overexpression of FosB, c-Fos, or c-Jun in HeLa cells is sufficient to cause derepression of transcription from the SERPINB2 promoter. Although FosB is likely to be involved in transactivator-mediated derepression of PAI-2 transcription in macrophage-like cells, as exemplified by the U937 cell line, c-Jun may be functional in other cell types. These data suggest a model for the transcriptional control of the human PAI-2 gene and further our understanding of the molecular basis for its tissue-specific expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22334683      PMCID: PMC3322994          DOI: 10.1074/jbc.M111.318758

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature.

Authors:  G A Silverman; P I Bird; R W Carrell; F C Church; P B Coughlin; P G Gettins; J A Irving; D A Lomas; C J Luke; R W Moyer; P A Pemberton; E Remold-O'Donnell; G S Salvesen; J Travis; J C Whisstock
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

2.  Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP.

Authors:  M Imagawa; R Chiu; M Karin
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

3.  DNA bending by Fos-Jun and the orientation of heterodimer binding depend on the sequence of the AP-1 site.

Authors:  N Rajaram; T K Kerppola
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

4.  Urokinase inhibitor in human placenta.

Authors:  T Kawano; K Morimoto; Y Uemura
Journal:  Nature       Date:  1968-01-20       Impact factor: 49.962

Review 5.  The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2.

Authors:  Robert L Medcalf; Stan J Stasinopoulos
Journal:  FEBS J       Date:  2005-10       Impact factor: 5.542

6.  Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation.

Authors:  Robert L Medcalf
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

7.  Transcriptional induction of collagenase-1 in differentiated monocyte-like (U937) cells is regulated by AP-1 and an upstream C/EBP-beta site.

Authors:  G A Doyle; R A Pierce; W C Parks
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

8.  Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2.

Authors:  S Kumar; C Baglioni
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

9.  Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.

Authors:  S Ganesh; C F Sier; M M Heerding; J H van Krieken; G Griffioen; K Welvaart; C J van de Velde; J H Verheijen; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 10.  An overview of the serpin superfamily.

Authors:  Ruby H P Law; Qingwei Zhang; Sheena McGowan; Ashley M Buckle; Gary A Silverman; Wilson Wong; Carlos J Rosado; Chris G Langendorf; Rob N Pike; Philip I Bird; James C Whisstock
Journal:  Genome Biol       Date:  2006-05-30       Impact factor: 13.583

View more
  6 in total

Review 1.  SERPINB2-its regulation and interplay with aryl hydrocarbon receptor.

Authors:  Damian Brauze
Journal:  J Appl Genet       Date:  2021-01-02       Impact factor: 3.240

2.  SerpinB2 mediated regulation of macrophage function during enteric infection.

Authors:  Terez Shea-Donohue; Aiping Zhao; Toni M Antalis
Journal:  Gut Microbes       Date:  2014-02-05

3.  microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival.

Authors:  Tiefeng Jin; Hoe Suk Kim; Sul Ki Choi; Eun Hye Hwang; Jisu Woo; Han Suk Ryu; Kwangsoo Kim; Aree Moon; Woo Kyung Moon
Journal:  Oncotarget       Date:  2017-05-16

4.  The transcription factor C/EBP-β mediates constitutive and LPS-inducible transcription of murine SerpinB2.

Authors:  Ekemini A Udofa; Brett W Stringer; Padmaja Gade; Donna Mahony; Marguerite S Buzza; Dhananjaya V Kalvakolanu; Toni M Antalis
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

5.  Global identification of the genetic networks and cis-regulatory elements of the cold response in zebrafish.

Authors:  Peng Hu; Mingli Liu; Dong Zhang; Jinfeng Wang; Hongbo Niu; Yimeng Liu; Zhichao Wu; Bingshe Han; Wanying Zhai; Yu Shen; Liangbiao Chen
Journal:  Nucleic Acids Res       Date:  2015-07-30       Impact factor: 16.971

6.  Auranofin Suppresses Plasminogen Activator Inhibitor-2 Expression through Annexin A5 Induction in Human Prostate Cancer Cells.

Authors:  Dong-Won Shin; Yeo-Jung Kwon; Dong-Jin Ye; Hyoung-Seok Baek; Joo-Eun Lee; Young-Jin Chun
Journal:  Biomol Ther (Seoul)       Date:  2017-03-01       Impact factor: 4.634

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.